Please use this identifier to cite or link to this item:
http://hdl.handle.net/10603/576024
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.coverage.spatial | Biotechnology | - |
dc.date.accessioned | 2024-07-09T11:39:49Z | - |
dc.date.available | 2024-07-09T11:39:49Z | - |
dc.identifier.uri | http://hdl.handle.net/10603/576024 | - |
dc.description.abstract | Available | - |
dc.format.extent | 147p. | - |
dc.language | English | - |
dc.relation | No. of Reference 267 | - |
dc.rights | university | - |
dc.title | Elucidation of role of acid ceramidase in inflammation driven colorectal cancer | - |
dc.title.alternative | - | - |
dc.creator.researcher | Yadu Vijayan | - |
dc.subject.keyword | Checkpoint therapy | - |
dc.subject.keyword | Colorectal cancer, Acid ceramidase | - |
dc.subject.keyword | LCL-521, Immunogenic cell death | - |
dc.description.note | bibliography p. 136-147 | - |
dc.contributor.guide | Harikumar, K B | - |
dc.publisher.place | Manipal | - |
dc.publisher.university | Manipal Academy of Higher Education | - |
dc.publisher.institution | Rajiv Gandhi Centre For Biotechnology | - |
dc.date.registered | 2018 | - |
dc.date.completed | 2024 | - |
dc.date.awarded | 2024 | - |
dc.format.dimensions | - | - |
dc.format.accompanyingmaterial | None | - |
dc.source.university | University | - |
dc.type.degree | Ph.D. | - |
Appears in Departments: | Rajiv Gandhi Centre For Biotechnology |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
01_title.pdf | Attached File | 178.91 kB | Adobe PDF | View/Open |
02_prelim pages.pdf | 2.97 MB | Adobe PDF | View/Open | |
03_content.pdf | 147.76 kB | Adobe PDF | View/Open | |
04_abstract.pdf | 147.6 kB | Adobe PDF | View/Open | |
05_chapter 1.pdf | 1.54 MB | Adobe PDF | View/Open | |
06_chapter 2.pdf | 1.46 MB | Adobe PDF | View/Open | |
07_annexures.pdf | 438.57 kB | Adobe PDF | View/Open | |
80_recommendation.pdf | 598.93 kB | Adobe PDF | View/Open |
Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).